Overview
To identify tumor specific DNA mutations and aberrations and to follow these in blood over time to predict treatment response/survival and secondly to correlate presence of these markers in blood to pathological parameters (LVI, Pn, WPOI and margins), radiological findings and to tumor stage.
Eligibility
Inclusion Criteria:
- Patient diagnosed with head and neck cancer
- Treatment includes surgery
- Consent to participate
Exclusion Criteria:
- No consent
- Age below 18 years
- No surgery
- No tumor material to sample